Opzelura® (ruxolitinib)
for Atopic Dermatitis – Eczema

Opzelura (ruxolitinib) is a topical prescription medicine used for the short-term, non-continuous treatment of mild to moderate eczema (atopic dermatitis) in non-immunocompromised individuals aged 12 and older who have not responded well to other topical treatments or cannot use them. It is also approved for treating nonsegmental vitiligo in adults and children 12 years and older.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Atopic Dermatitis - Eczema